Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Berry

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Gut|September 16, 2020
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinomaRobert C Grant, Robert Denroche, Gun Ho Jang, et al.
JAMA|May 20, 2019
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for SepsisChristopher W Seymour, Jason N Kennedy, Shu Wang, et al.
JAMA|March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021Eliya Farah, Maria El Bizri, Radmila Day, et al.
JAMA|June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical TrialAlan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
JAMA Network Open|April 12, 2022
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, J Ryan Bariola, Richard J Wadas, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
Nature Biomedical Engineering|December 5, 2024
Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genesJiang-An Yin, Lukas Frick, Manuel C Scheidmann, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024Jennifer Leigh, Arwa Ahmed, Francine Aubin, et al.
The New England Journal of Medicine|September 4, 2024
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic StrokeOpeolu Adeoye, Joseph Broderick, Colin P Derdeyn, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Gut|September 16, 2020
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinomaRobert C Grant, Robert Denroche, Gun Ho Jang, et al.
JAMA|May 20, 2019
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for SepsisChristopher W Seymour, Jason N Kennedy, Shu Wang, et al.
JAMA|March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021Eliya Farah, Maria El Bizri, Radmila Day, et al.
JAMA|June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical TrialAlan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
JAMA Network Open|April 12, 2022
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, J Ryan Bariola, Richard J Wadas, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
Nature Biomedical Engineering|December 5, 2024
Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genesJiang-An Yin, Lukas Frick, Manuel C Scheidmann, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024Jennifer Leigh, Arwa Ahmed, Francine Aubin, et al.
The New England Journal of Medicine|September 4, 2024
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic StrokeOpeolu Adeoye, Joseph Broderick, Colin P Derdeyn, et al.
Pageof 15